Skip to main content
. 2014 Aug 13;23(5):610–615. doi: 10.1038/ejhg.2014.162

Table 2. Clinical features of Malan syndrome patients with pathogenic NFIX variants and deletions reported here and in the literature.

  All Deletion of NFIX and other genes including CACNA1A Deletion of NFIX excluding CACNA1A Nonsense or frameshift NFIX variant Missense or in-frame NFIX variant
Number of patients 20 8 6 3 3
Median birthweight (SD) +0.3 0 +0.9 +0.2 −0.4
Median length/height (SD)a +2.0 +1.4 +1.7 +2.5 +3.8
Median weight (SD)a +0.6 +1.2 +1.2 +1.3 +0.6
Median OFC (SD)a +2.3 +2.1 +2.3 +2.5 +2.8
           
Developmental delay
 Mild 1 (5%) 0 0 0 1
 Moderate 15 (75%) 7 5 2 1
 Severe 4 (20%) 1 1 1 1
Neonatal feeding difficulties/hypotonia 6/20 (30%) 2/8 3/6 0/3 1/3
Seizures 5/20 (25%) 1/8 3/6 0/3 1/3
Episodic ataxia 1/20 (5%) 1/8 0/6 0/3 0/3
Migraine 1/20 (5%) 1/8 0/6 0/3 0/3
Nystagmus 5/20 (25%) 2/8 1/6 1/3 1/3
Strabismus 13/20 (65%) 5/8 4/6 2/3 2/3
Optic disc pallor/hypoplasia 5/20 (25%) 1/8 3/6 0/3 1/3
Advanced bone age 6/7 (86%) 1/1 2/3 2/2 2/2
Scoliosis 5/20 (25%) 0/8 2/6 1/3 2/3
Pectus excavatum 8/20 (40%) 2/8 3/6 1/3 2/3

Abbreviations: OFC, occipital-frontal circumference; N/A, not available; SD, standard deviations above (+) or below (−) mean.

Genomic positions are given according to the HG19 build.

a

Measurement at last assessment in clinic.